Keiretsu Forum Mid Atlantic

investment firm

About

Keiretsu Forum Mid-Atlantic offers you access to a wealth of international angel funding opportunities, vetted by business experts with

Details

Founded date
Jan 1, 2010
Operating Status
Active
Investor Type
Venture Capital

Keiretsu Forum Mid-Atlantic offers you access to a wealth of international angel funding opportunities, vetted by business experts with local first hand knowledge of every investment.

Investments

Number of Investments
Number of Lead Investments
10
5
Keiretsu Forum Mid Atlantic has made 10 investments. Their most recent investment was on Oct 19, 2022, when FEMSelect raised $9M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 19, 2022 FEMSelect
Series B $9M Health Care
Aug 31, 2022 iQure Pharma
Series A $600K Biotechnology Yes
Series A $3M Battery Yes
Jul 1, 2019 ExpressCells
Series A $1.20M Biotechnology Yes
Mar 7, 2019 Astarte Medical
Series A $5M Analytics

Employee Profiles

Number of Employee Profiles
3
Keiretsu Forum Mid Atlantic has 3 current employee profiles, including Executive Vincent Leusner
Executive
Executive
Executive

Exits

Keiretsu Forum Mid Atlantic has had 1 exits. Keiretsu Forum Mid Atlantic most notable exits include Savara Pharmaceuticals

Date Company Name Exit Type Industry
Jun 1, 2017 Savara Pharmaceuticals M&A Biopharma Detail